Osteopontin and 'melanoma inhibitory 1activity': Comparison of two serological tumor markers in metastatic uveal melanoma patients

Ophthalmologica

Volumn 223, Issue 4, 2009, Pages 239-243

  Haritoglou, Ingrid ^a   Wolf, Armin ^a   Maier, Tanja ^a   Haritoglou, Christos ^a   Hein, Rüdiger ^b   Schaller, Ulrich Christoph ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Melanoma inhibitory activity; Metastases; Osteopontin; Serological marker; Uveal melanoma

Indexed keywords

MELANOMA INHIBITORY ACTIVITY PROTEIN; OSTEOPONTIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER SCREENING; CLINICAL ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METASTASIS; STATISTICAL SIGNIFICANCE; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; OSTEOPONTIN; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 61449206186     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000206139     Document Type: Article

References (20)

1. Kivelä T, Eskelin S , Kuja la E: Metastatic uvea l melanoma. Int Ophtha lmol Clin 20 06;46:133-149.
2. Mooy CM, De Jong PT: Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996;41:215-228.
3. Bedikian AY: Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 2006;46:151-166.
4. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Green DL, Hawkins BS, Hayman J, Jaiyesimi I, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Thoma J: Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 2004; 22:2438-2444.
5. Eskelin S, Pyrhönen S, Summanen P, Prause JU, Kivelä T: Screening for metastatic malignant melanoma of the uvea revisited. Cancer 1999;85:1151-1159.
6. Reiniger IW, Schaller UC, Haritoglou C, Hein R, Bosserhoff AK, Kampik A, Mueller AJ: 'Melanoma inhibitory activity' (MIA): a promising serological tumour marker in metastatic uveal melanoma. Graefes Arch Clin Exp Opht ha lmol 2005;243:1161-1166.
7. Schaller UC, Mueller AJ, Bosserhoff AK, Haraida S, Löhrs U, Buettner R, Kampik A: Melanoma inhibitory activity (MIA). Evaluation of a new tumor-associated antigen as a serum marker for uveal melanomas. Ophthalmologe 2000;97:429-432.
8. Schaller UC, Bosserhoff AK, Neubauer AS, Buettner R, Kampik A, Mueller AJ: Melanoma inhibitory activity: a novel serum marker for uveal melanoma. Melanoma Res 2002;12: 593-599.
9. Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J: Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Opht ha lmol Vis Sci 2006;47:802-806.
10. Reiniger IW, Wolf A, Welge-Lü ssen U, Mueller AJ, Kampik A, Schaller UC: Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Am J Ophtha lmol 2007;143:705-707.
11. Rittling SR, Chambers AF: Role of osteopon-tin in tumor progression. Br J Cancer 2004; 90:1877-1881.
12. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994;145:610-623.
13. Zhou Y, Dai DL, Martinka M, Su M, Zhang Y, Campos EI, Dorocicz I, Tang L, Huntsman D, Nelson C, Ho V, Gang L: Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 2005;124:1044-1052.
14. Ossoinig KC, Bigar F, Kaefring SL: Malignant melanoma of the choroid and ciliary body. A differential diagnosis in clinical echography. Bibl Ophthalmol 1975;83:141-154.
15. Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R, Stolz W, Buettner R: Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res 1997;57:3149-3153.
16. Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J: The microcirculation of choroidal and ciliary body melanomas. Eye 1997;11:227-238.
17. Barak V, Frenkel S, Kalickman I, Maniotis AJ, Folberg R, Pe'er J: Serum markers to detect metastatic uveal melanoma. Anticancer Res 2007;27:1897-1900.
18. Standal T, Borset M, Sundan A: Role of os-teopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004; 26:179-184.
19. Stieber P, Heinemann V, Schalhorn A: Tumor markers - how they should be applied. MMW For tschr Med 2005;147:35, 37-39.
20. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-298.